Search

everythinglearnresearchcommunity

for

Search:↓

Frontal Fibrosing Alopecia might be an autoimmune disease.

The document suggests that severe hair loss in SLE patients may be an early sign of scalp DLE, treatable with immunosuppressive therapy.

Treatments for autoimmune hair loss have limited success and often relapse, and emotional support is crucial for those affected.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

A woman's scalp infection caused by a fungus led to permanent hair loss and was hard to treat but responded to a specific antifungal.

Frontal Fibrosing Alopecia mainly affects postmenopausal Mexican women, requiring early detection to prevent permanent hair loss.

COVID-19 may worsen hair loss in people with a certain type of scarring alopecia, but early treatment can help improve symptoms and hair regrowth.

Changing certain hairstyles can prevent worsening hair loss in Mexican women.

Targeting cholesterol, fatty acids, fibrosis, and mast cells may help treat CCCA.

Elderly patients with CCCA were all African American with low vitamin D, but no iron or zinc deficiencies, and no hormonal imbalances compared to younger patients.

Frontal Fibrosing Alopecia is a type of hair loss affecting mostly older women, with no agreed best treatment.

Cicatricial alopecia causes permanent hair loss and is treated to relieve symptoms and stop progression.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Hair loss in African American women, caused by hair care, genetics, and environment, needs more research for better treatment.

Alopecia areata is a type of hair loss that can lead to complete baldness, often associated with other autoimmune conditions, and half of the cases may see hair return within a year.

CCCA is a hair loss type affecting African women, possibly caused by grooming and chemicals, with various treatments and needing more research.

Using both vertical and transverse sections gives a better diagnosis of alopecia than using one method alone.

Psoriasis can cause temporary or permanent hair loss.

The document concludes that better treatments for CCCA are needed and more research is required to understand its causes related to hairstyling and genetics.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Fibrosing alopecia in a pattern distribution is a hair loss condition often confused with other types, requiring early treatment but usually not resulting in significant hair regrowth.

Alopecia areata involves immune response and gene changes affecting hair loss.

EVG staining is the most reliable method for diagnosing alopecia.

Platelet-Rich Plasma (PRP) can promote new hair growth and increase hair density, but its effectiveness varies depending on the type of hair loss.

Scalp areas that look normal in people with hair loss may still show signs of disease under a microscope.

The study found that the cause of alopecia areata can be identified through tissue analysis, and vertical sections are enough for diagnosis.

Pediatricians should treat some hair loss types in children and refer others to a dermatologist.

AGA treatments like minoxidil and LLLLT are safe and effective for gender minority patients.

Early treatment of fibrosing alopecia in a pattern distribution may improve outcomes.